Xigris

Drotrecogin alfa (activated) · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Xigris, covering 2006-07-20 to 2022-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Dose Finding Study of Xigris in Hemodialysis Patients [Phase 2]